Silodosin & Dutasteride Capsules Manufacturer in India & Exporter | Contract Manufacturing

Silodosin & Dutasteride Capsules

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 8 mg & 0.5 mg, 4 mg + 0.5 mg

Silodosin & Dutasteride Capsules are an advanced dual-combination therapy formulated for the effective management of benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) in men. This combination delivers both rapid symptomatic relief and long-term disease control:

Silodosin (alpha-1 adrenergic blocker) relaxes smooth muscles in the prostate and bladder neck, improving urine flow
Dutasteride (5-alpha reductase inhibitor) reduces dihydrotestosterone (DHT) levels, helping shrink the prostate over time

Genliva Wellness LLP is a trusted Silodosin & Dutasteride Capsules manufacturer in India, offering high-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a reliable Silodosin Dutasteride Capsules exporter and contract manufacturer, the company ensures global-quality standards, consistent efficacy, and regulatory compliance.

With strong expertise in pharmaceutical contract manufacturing, third-party capsule production, and international export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, supporting urology specialists, hospitals, and global distributors.

Send Message

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Silodosin (alpha-1 adrenergic blocker) relaxes smooth muscles in the prostate and bladder neck, improving urine flow
Dutasteride (5-alpha reductase inhibitor) reduces dihydrotestosterone (DHT) levels, helping shrink the prostate over time

Leading Silodosin & Dutasteride Capsules manufacturer in India with GMP certification
Reliable Silodosin Dutasteride Capsules exporter for global pharmaceutical markets
Specialized Silodosin Dutasteride Capsules contract manufacturer for third-party production
Dual-action formulation for immediate symptom relief and prostate size reduction
Silodosin provides fast relief from urinary obstruction and LUTS symptoms
Dutasteride ensures long-term control of prostate enlargement (DHT suppression)
Available in standard combinations such as Silodosin 8 mg + Dutasteride 0.5 mg capsules
Manufactured using high-quality APIs under strict quality assurance protocols
Suitable for bulk supply, institutional procurement, and long-term therapy markets
Offered with custom packaging, private labeling, and export documentation support
Backed by Genliva’s reputation as a global pharmaceutical exporter from India

Silodosin & Dutasteride Capsules are widely used in urology for:

Treatment of benign prostatic hyperplasia (BPH)
Management of lower urinary tract symptoms (LUTS)
Improvement of urinary flow and bladder emptying
Relief from symptoms such as:
- Frequent urination
- Weak urine stream
- Hesitancy and incomplete emptying
- Nocturia
Reduction in prostate size over time
Prevention of acute urinary retention (AUR)

Decreasing the need for surgical intervention

Capsule dosage form ensures enhanced absorption and bioavailability
Easy-to-swallow format improves patient compliance
Combination therapy reduces need for multiple medications
Provides both short-term relief and long-term disease management
Stable formulation suitable for export and long shelf life
Available in blister packs and bulk export packaging formats
Ideal for private label pharmaceutical brands and distributors